Acquiring Company
Juvenescence
Acquired Company
Ro5
LondonOtherBiotechnologyBiotechnologyArtificial IntelligenceMachine LearningDescription
Juvenescence has acquired drug discovery firm Ro5 to enhance its AI and machine learning capabilities in drug discovery. This acquisition is pivotal for Juvenescence's partnership with the global healthcare company M42. The collaboration aims to accelerate the development of therapeutics targeting age-related diseases. Ro5's extensive AI Chemistry Platform will bolster Juvenescence's research and development efforts.
Quick answer
Juvenescence is acquiring Ro5, announced June 9, 2025.
- How much did Juvenescence pay for Ro5?
- The deal value was not disclosed.
- What does Juvenescence do?
- Juvenescence is a biotechnology company focused on developing therapies aimed at extending healthy lifespan.
- Where are Juvenescence and Ro5 based?
- Ro5 is based in London, England, United Kingdom.
- Who are the decision-makers at Juvenescence?
- Fundz holds 2 contacts at Juvenescence. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- XtalPi acquires Liverpool ChiroChem for innovation boost (June 13, 2025)
- Nvidia acquires Canadian AI startup CentML (June 27, 2025)
- Qiagen acquires Genoox for $80 million, $80M (May 12, 2025)
- HEALWELL acquires full ownership of Pentavere (July 16, 2025)
- Meta acquires PlayAI to enhance AI voice capabilities (July 12, 2025)
- GHO Capital to acquire FotoFinder Systems (July 8, 2025)
Who to call at Juvenescence, and when
When Juvenescence changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Juvenescence raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Juvenescence, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Juvenescence. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Juvenescence makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ro5?
Ro5 was acquired by Juvenescence. The deal was reported on June 9, 2025. Juvenescence is a biotechnology company focused on developing therapies aimed at extending healthy lifespan. The company utilizes AI and machine learning in its drug discovery process. Juvenescence is privately held and operates in Other.
When did Juvenescence acquire Ro5?
Juvenescence's acquisition of Ro5 was reported on June 9, 2025. Juvenescence has acquired drug discovery firm Ro5 to enhance its AI and machine learning capabilities in drug discovery. This acquisition is pivotal for Juvenescence's partnership with the global healthcare company M42. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ro5 do?
Ro5 is a drug discovery firm specializing in AI-driven chemistry solutions. The company develops advanced machine learning models and cheminformatics tools to optimize drug discovery processes. It has extensive data on biological processes and drug targets. It is privately held, operating in Biotechnology, and is based in London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.